Suppr超能文献

戊巴比妥疗法并不能改善近乎溺亡、处于弛缓性昏迷状态儿童的神经学预后。

Pentobarbital therapy does not improve neurologic outcome in nearly drowned, flaccid-comatose children.

作者信息

Nussbaum E, Maggi J C

机构信息

Pediatric Critical Care Center, Miller Children's Hospital of Long Beach, CA 90801-1428.

出版信息

Pediatrics. 1988 May;81(5):630-4.

PMID:3357724
Abstract

The effect of pentobarbital therapy was studied prospectively in 31 nearly drowned children in a flaccid state of coma. Each child was assigned to one of two sequential treatment groups. Group A: 16 children were treated with hypothermia and IV pentobarbital, achieving serum levels greater than 25 mu/mL within 48 hours of admission. Group B: 15 children were treated with hypothermia but no pentobarbital. All patients received "conventional therapy" (ie, PaCO2 20 to 25 mm Hg, PaO2 90 to 100 mm Hg, fluid restriction, pancuronium bromide, and furosemide or mannitol). Analysis of variance failed to detect differences for age, estimated time of submersion, arterial pH, core temperature, and mean intracranial pressure between the patients prior to treatment with pentobarbital. In Group A, six patients (37%) recovered completely and were neurologically intact, six patients (37%) had severe brain damage and four patients (26%) died. In Group B, six patients (40%) recovered completely, six patients (40%) survived with brain damage, and three patients (20%) died. There were no statistical differences between the two groups (P greater than .05, chi 2 analysis) for the mortality rate, survival with brain damage, and complete recovery. The results suggest that: (1) pentobarbital therapy does not improve neurologic outcome for nearly drowned, flaccid-comatose children; (2) previous claims implying better outcome with hypothermia combined with pentobarbital therapy may be attributed to the effect of hypothermia alone; and (3) pentobarbital therapy may not be justified in nearly drowned, flaccid-comatose victims.

摘要

对31名处于弛缓性昏迷状态的近乎溺水儿童进行了戊巴比妥治疗效果的前瞻性研究。每个孩子被分配到两个连续治疗组中的一组。A组:16名儿童接受低温治疗并静脉注射戊巴比妥,入院后48小时内血清水平大于25μg/mL。B组:15名儿童接受低温治疗但未使用戊巴比妥。所有患者均接受“常规治疗”(即动脉血二氧化碳分压20至25mmHg,动脉血氧分压90至100mmHg,液体限制,泮库溴铵,以及呋塞米或甘露醇)。方差分析未能检测出在使用戊巴比妥治疗前患者之间在年龄、估计溺水时间、动脉pH值、核心体温和平均颅内压方面的差异。在A组中,6名患者(37%)完全康复且神经功能完好,6名患者(37%)有严重脑损伤,4名患者(26%)死亡。在B组中,6名患者(40%)完全康复,6名患者(40%)存活但有脑损伤,3名患者(20%)死亡。两组在死亡率、存活且有脑损伤以及完全康复方面无统计学差异(P大于0.05,卡方分析)。结果表明:(1)戊巴比妥治疗不能改善近乎溺水、弛缓性昏迷儿童的神经功能结局;(2)先前声称低温联合戊巴比妥治疗有更好结局可能归因于单纯低温的作用;(3)对于近乎溺水、弛缓性昏迷的受害者,戊巴比妥治疗可能不合理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验